ACCC launches immuno-oncology initiative

The Association of Community Cancer Centers (ACCC) launched the Institute for Clinical Immuno-Oncology (ICLIO), an educational initiative to increase adoption of immuno-oncology therapies. Bristol-Myers Squibb Co. (NYSE:BMY) donated an undisclosed sum to support the initiative.

ACCC spokesperson Lori Gardner told BioCentury ICLIO seeks to provide educational tools to physicians, academics, insurers, social workers and other parties involved in patient access to cancer immunotherapies. ICLIO will provide free newsletters and online courses; it plans to host a conference in October and start a preceptorship program next year. ...